Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07171463

Pulsed Field Ablation With Concomitant Radiofrequency Cardioneuroablation in Patients With Paroxysmal Atrial Fibrillation

Evaluation of the Safety and Efficacy of Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation Using Point-by-Point Bipolar Pulsed Field Ablation Combined With Thermal Ablation of the Superior Paraseptal Parasympathetic Ganglion Region

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
St. Joseph's Centre, Poland · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pulsed-field ablation (PFA) is a novel, non-thermal method for the treatment of atrial fibrillation (AF). It uses short, high-voltage electrical pulses to selectively ablate cardiomyocytes. PFA has demonstrated a high safety profile with reduced complication rates compared to thermal ablation. Thermal ablation of parasympathetic ganglia during conventional pulmonary vein isolation (PVI) may improve long-term procedural outcomes by reducing AF recurrence. However, due to its non-thermal nature, PFA may not significantly affect cardiac autonomic innervation, which could be clinically relevant in vagally mediated AF or tachycardia-bradycardia syndrome. This randomized study compares two strategies: (1) PFA-only PVI, and (2) PFA combined with selective thermal ablation (radiofrequency energy) of the superior paraseptal parasympathetic ganglion. The primary objective is to evaluate whether adjunctive thermal ablation improves clinical outcomes and reduces intraprocedural bradyarrhythmic events.

Conditions

Interventions

TypeNameDescription
PROCEDUREPulmonary Vein Isolation using Point-by-Point Bipolar Pulsed-Field AblationPulmonary vein isolation is performed via transseptal access to the left atrium using a point-by-point bipolar pulsed-field ablation catheter
PROCEDURESelective Radiofrequency Ablation of the Superior Paraseptal Parasympathetic GanglionTargeted application of radiofrequency energy at the anterior aspect of the right superior pulmonary vein, corresponding to the anatomical location of the superior paraseptal parasympathetic ganglion.

Timeline

Start date
2025-05-26
Primary completion
2025-09-30
Completion
2026-09-30
First posted
2025-09-12
Last updated
2025-09-12

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT07171463. Inclusion in this directory is not an endorsement.